» Articles » PMID: 23869227

Multi-scale Modeling Predicts a Balance of Tumor Necrosis Factor-α and Interleukin-10 Controls the Granuloma Environment During Mycobacterium Tuberculosis Infection

Overview
Journal PLoS One
Date 2013 Jul 23
PMID 23869227
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin-10 (IL-10) and tumor necrosis factor-α (TNF-α) are key anti- and pro-inflammatory mediators elicited during the host immune response to Mycobacterium tuberculosis (Mtb). Understanding the opposing effects of these mediators is difficult due to the complexity of processes acting across different spatial (molecular, cellular, and tissue) and temporal (seconds to years) scales. We take an in silico approach and use multi-scale agent based modeling of the immune response to Mtb, including molecular scale details for both TNF-α and IL-10. Our model predicts that IL-10 is necessary to modulate macrophage activation levels and to prevent host-induced tissue damage in a granuloma, an aggregate of cells that forms in response to Mtb. We show that TNF-α and IL-10 parameters related to synthesis, signaling, and spatial distribution processes control concentrations of TNF-α and IL-10 in a granuloma and determine infection outcome in the long-term. We devise an overall measure of granuloma function based on three metrics - total bacterial load, macrophage activation levels, and apoptosis of resting macrophages - and use this metric to demonstrate a balance of TNF-α and IL-10 concentrations is essential to Mtb infection control, within a single granuloma, with minimal host-induced tissue damage. Our findings suggest that a balance of TNF-α and IL-10 defines a granuloma environment that may be beneficial for both host and pathogen, but perturbing the balance could be used as a novel therapeutic strategy to modulate infection outcomes.

Citing Articles

Shaping Rare Granulomatous Diseases in the Lab: How New Models Are Changing the Game.

Ceccato J, Gualtiero G, Piazza M, Carraro S, Buso H, Felice C Cells. 2025; 14(4).

PMID: 39996765 PMC: 11853845. DOI: 10.3390/cells14040293.


A brief overview of mathematical modeling of the within-host dynamics of Mycobacterium tuberculosis.

Chakraborty D, Batabyal S, Ganusov V Front Appl Math Stat. 2025; 10.

PMID: 39906541 PMC: 11793202. DOI: 10.3389/fams.2024.1355373.


In silico agent-based modeling approach to characterize multiple in vitro tuberculosis infection models.

Petrucciani A, Hoerter A, Kotze L, Plessis N, Pienaar E PLoS One. 2024; 19(3):e0299107.

PMID: 38517920 PMC: 10959380. DOI: 10.1371/journal.pone.0299107.


Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens.

Budak M, Cicchese J, Maiello P, Jacob Borish H, White A, Chishti H PLoS Comput Biol. 2023; 19(6):e1010823.

PMID: 37319311 PMC: 10306236. DOI: 10.1371/journal.pcbi.1010823.


A computational modeling approach for predicting multicell spheroid patterns based on signaling-induced differential adhesion.

Sivakumar N, Warner H, Peirce S, Lazzara M PLoS Comput Biol. 2022; 18(11):e1010701.

PMID: 36441822 PMC: 9747056. DOI: 10.1371/journal.pcbi.1010701.


References
1.
Marfaing-Koka A, Maravic M, Humbert M, Galanaud P, Emilie D . Contrasting effects of IL-4, IL-10 and corticosteroids on RANTES production by human monocytes. Int Immunol. 1996; 8(10):1587-94. DOI: 10.1093/intimm/8.10.1587. View

2.
Murray P . The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc Natl Acad Sci U S A. 2005; 102(24):8686-91. PMC: 1150817. DOI: 10.1073/pnas.0500419102. View

3.
Wigginton J, Kirschner D . A model to predict cell-mediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis. J Immunol. 2001; 166(3):1951-67. DOI: 10.4049/jimmunol.166.3.1951. View

4.
Harris J, Hope J, Keane J . Tumor necrosis factor blockers influence macrophage responses to Mycobacterium tuberculosis. J Infect Dis. 2008; 198(12):1842-50. DOI: 10.1086/593174. View

5.
Chakravarty S, Zhu G, Tsai M, Mohan V, Marino S, Kirschner D . Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs. Infect Immun. 2008; 76(3):916-26. PMC: 2258824. DOI: 10.1128/IAI.01011-07. View